Assembly Biosciences Inc (ASMB)
17.05
+0.35
(+2.10%)
USD |
NASDAQ |
Nov 14, 16:00
16.79
-0.26
(-1.52%)
After-Hours: 20:00
Assembly Biosciences Cash from Operations (Quarterly): -17.10M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -17.10M |
| March 31, 2024 | -18.36M |
| December 31, 2023 | 73.65M |
| September 30, 2023 | -13.85M |
| June 30, 2023 | -13.63M |
| March 31, 2023 | -23.43M |
| December 31, 2022 | -19.25M |
| September 30, 2022 | -19.82M |
| June 30, 2022 | -17.88M |
| March 31, 2022 | -27.50M |
| December 31, 2021 | -19.36M |
| September 30, 2021 | -18.88M |
| June 30, 2021 | -21.81M |
| March 31, 2021 | -33.34M |
| December 31, 2020 | -25.27M |
| September 30, 2020 | 10.65M |
| June 30, 2020 | -23.12M |
| March 31, 2020 | -25.22M |
| December 31, 2019 | -20.53M |
| September 30, 2019 | -18.60M |
| June 30, 2019 | -21.00M |
| March 31, 2019 | -23.94M |
| December 31, 2018 | -16.73M |
| September 30, 2018 | -16.68M |
| June 30, 2018 | -16.05M |
| Date | Value |
|---|---|
| March 31, 2018 | -15.50M |
| December 31, 2017 | -9.770M |
| September 30, 2017 | -10.96M |
| June 30, 2017 | -12.36M |
| March 31, 2017 | 34.94M |
| December 31, 2016 | -11.04M |
| September 30, 2016 | -7.864M |
| June 30, 2016 | -6.768M |
| March 31, 2016 | -9.210M |
| December 31, 2015 | -5.455M |
| September 30, 2015 | -5.186M |
| June 30, 2015 | -4.383M |
| March 31, 2015 | -3.673M |
| December 31, 2014 | -3.593M |
| September 30, 2014 | -3.875M |
| June 30, 2014 | -2.320M |
| March 31, 2014 | -5.185M |
| December 31, 2013 | -5.392M |
| September 30, 2013 | -4.655M |
| June 30, 2013 | -3.378M |
| March 31, 2013 | -4.370M |
| December 31, 2012 | -3.071M |
| September 30, 2012 | -5.284M |
| June 30, 2012 | -6.936M |
| March 31, 2012 | -6.090M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-33.34M
Minimum
Mar 2021
73.65M
Maximum
Dec 2023
-14.42M
Average
-19.36M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| ADMA Biologics Inc | 25.03M |
| Sensus Healthcare Inc | 4.23M |
| Protagonist Therapeutics Inc | -27.86M |
| Precision BioSciences Inc | -5.912M |
| Entrada Therapeutics Inc | -24.27M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 5.107M |
| Cash from Financing (Quarterly) | 12.45M |
| Free Cash Flow | 24.10M |
| Free Cash Flow Per Share (Quarterly) | -3.033 |
| Free Cash Flow to Equity (Quarterly) | -17.12M |
| Free Cash Flow to Firm (Quarterly) | -17.12M |
| Free Cash Flow Yield | 27.14% |